Your session is about to expire
← Back to Search
Non-Pharmacological Therapy
Transcranial Direct Current Stimulation for Schizophrenia
N/A
Waitlist Available
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessment will begin immediately following stimulation and last for up to an hour.
Awards & highlights
Study Summary
This trial is testing whether transcranial direct current stimulation (tDCS) can help people with schizophrenia better understand and use cognitive control, a process that is essential for goal-directed behavior. tDCS is a noninvasive method of applying a weak electrical current to the brain. The study will also use functional magnetic resonance imaging (fMRI) to examine the effects of tDCS on the neuronal mechanisms of cognitive control in schizophrenia.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ assessment will begin immediately following stimulation and last for up to an hour.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessment will begin immediately following stimulation and last for up to an hour.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Behavioral Response
Dorsolateral Prefrontal Cortex Response
Side effects data
From 2021 Phase 2 & 3 trial • 160 Patients • NCT024834682%
Car accident
2%
skin irritation
100%
80%
60%
40%
20%
0%
Study treatment Arm
tDCS (Active)
tDCS (Sham)
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Experimental StimulationExperimental Treatment1 Intervention
Intervention. 20 minutes of 2 mA direct current stimulation over the dorsolateral prefrontal cortex
Group II: Sham StimulationPlacebo Group1 Intervention
Placebo Comparator. 0.5-1 minutes of 2 mA direct current stimulation over the dorsolateral prefrontal cortex followed by 19-19.5 minutes of sham stimulation
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transcranial Direct Current Stimulation
2014
Completed Phase 3
~1100
Find a Location
Who is running the clinical trial?
University of California, DavisLead Sponsor
914 Previous Clinical Trials
4,720,709 Total Patients Enrolled
3 Trials studying Schizophrenia
285 Patients Enrolled for Schizophrenia
Cameron Carter, M.D.Study DirectorUniversity of California, Davis
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have made changes to your psychiatric medication within the past month.You have a device implanted in your brain to stimulate it.You have skin damage or conditions like eczema where the electrodes will be placed.You have had a recent injury to your head.You have a device called a defibrillator implanted in your body.You have epilepsy, a condition that causes seizures.You have a brain or nerve-related condition.You have metallic implants in your body.You have a condition called mental retardation, which affects your thinking and learning abilities.You have a pacemaker.You have vision problems that make it difficult for you to complete cognitive tests or tasks that require distinguishing colors.You have been diagnosed with schizophrenia, schizophreniform disorder, or schizoaffective disorder.
Research Study Groups:
This trial has the following groups:- Group 1: Sham Stimulation
- Group 2: Experimental Stimulation
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger